Lymphocyte Subsets in Defense Against New Pathogens in Patients with Cancer.
María Del Carmen Arango-PradoCarlos A Villegas-ValverdeGriselda Torres-LópezPilar Soto-PardeiroAnamary Suárez-ReyesMaría E Faxas-GarcíaVivian Diéguez-RodríguezElias GraciaRoberto Esperón-NoaRamón Del Castillo-BahiAriadna Méndez-RosabalLuis Curbelo-AlfonsoPublished in: MEDICC review (2022)
Cancer and conventional cancer therapies significantly affect peripheral blood B lymphocyte levels, particularly transitional T helper lymphocytes, reducing the immune system's ability to trigger primary immune responses against new antigens.